XML 67 R48.htm IDEA: XBRL DOCUMENT v3.19.2
Summary of business and significant accounting policies - Adopted Accounting Pronouncements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Assets                      
Deferred costs $ 18,752       $ 11,759 [1]       $ 18,752 $ 11,759 [1]  
Deferred costs, non-current 61,050       46,666 [1]       61,050 46,666 [1]  
Total assets 297,015       237,680 [1]       297,015 237,680 [1]  
Liabilities and stockholders’ equity                      
Deferred revenue 31,270       20,714 [1]       31,270 20,714 [1]  
Deferred revenue, non-current 103,865       53,824 [1]       103,865 53,824 [1]  
Accumulated deficit (90,279)       (57,202) [1]       (90,279) (57,202) [1]  
Total liabilities and stockholders’ equity 297,015       237,680 [1]       297,015 237,680 [1]  
Revenue:                      
Total revenue 58,452 $ 53,069 $ 57,176 $ 52,199 55,987 $ 46,382 $ 61,399 $ 54,695 220,896 218,463 [1] $ 209,715 [1]
Cost of revenue:                      
Total cost of revenue                 124,675 128,071 [1] 120,436 [1]
Gross profit 26,357 23,442 24,985 21,437 24,164 21,715 23,523 20,990 96,221 90,392 [1] 89,279 [1]
Operating expenses:                      
Research and development                 83,953 85,646 [1] 67,406 [1]
Total operating expenses                 130,342 131,047 [1] 118,866 [1]
Loss from operations                 (34,121) (40,655) [1] (29,587) [1]
Net loss $ (12,856) $ (7,481) $ (4,581) $ (7,570) $ (7,465) $ (14,457) $ (8,394) $ (10,518) $ (32,488) [2] $ (40,834) [1],[2] $ (29,536) [1],[2]
Net loss per share, basic and diluted (in dollars per share) $ (0.28) $ (0.16) $ (0.10) $ (0.17) $ (0.17) $ (0.32) $ (0.19) $ (0.24) $ (0.71) $ (0.92) [1] $ (0.68) [1]
As Reported                      
Assets                      
Deferred costs         $ 31,888         $ 31,888  
Deferred costs, non-current         109,269         109,269  
Total assets         320,412         320,412  
Liabilities and stockholders’ equity                      
Deferred revenue         52,871         52,871  
Deferred revenue, non-current         182,236         182,236  
Accumulated deficit         (135,042)         (135,042)  
Total liabilities and stockholders’ equity         320,412         320,412  
Revenue:                      
Total revenue                   106,180 $ 169,584
Cost of revenue:                      
Total cost of revenue                   62,230 92,335
Gross profit                   43,950 77,249
Operating expenses:                      
Research and development                   87,488 73,102
Total operating expenses                   132,889 124,562
Loss from operations                   (88,939) (47,313)
Net loss                   $ (89,118) $ (47,262)
Net loss per share, basic and diluted (in dollars per share)                   $ (2.00) $ (1.09)
Product                      
Revenue:                      
Total revenue                 $ 168,619 $ 163,599 [1] $ 155,025 [1]
Cost of revenue:                      
Total cost of revenue                 97,245 102,224 [1] 98,531 [1]
Product | As Reported                      
Revenue:                      
Total revenue                   59,143 119,785
Cost of revenue:                      
Total cost of revenue                   37,517 70,260
Services                      
Revenue:                      
Total revenue                 52,277 54,864 [1] 54,690 [1]
Cost of revenue:                      
Total cost of revenue                 $ 27,430 25,847 [1] 21,905 [1]
Services | As Reported                      
Revenue:                      
Total revenue                   47,037 49,799
Cost of revenue:                      
Total cost of revenue                   24,713 22,075
Accounting Standards Update 2014-09 | Adjustments                      
Assets                      
Deferred costs         (20,129)         (20,129)  
Deferred costs, non-current         (62,603)         (62,603)  
Total assets         (82,732)         (82,732)  
Liabilities and stockholders’ equity                      
Deferred revenue         (32,157)         (32,157)  
Deferred revenue, non-current         (128,412)         (128,412)  
Accumulated deficit         77,840         77,840  
Total liabilities and stockholders’ equity         $ (82,732)         (82,732)  
Revenue:                      
Total revenue                   112,283 40,131
Cost of revenue:                      
Total cost of revenue                   65,841 28,101
Gross profit                   46,442 12,030
Operating expenses:                      
Research and development                   (1,842) (5,696)
Total operating expenses                   (1,842) (5,696)
Loss from operations                   48,284 17,726
Net loss                   $ 48,284 $ 17,726
Net loss per share, basic and diluted (in dollars per share)                   $ 1.08 $ 0.41
Accounting Standards Update 2014-09 | Product | Adjustments                      
Revenue:                      
Total revenue                   $ 104,456 $ 35,240
Cost of revenue:                      
Total cost of revenue                   64,707 28,271
Accounting Standards Update 2014-09 | Services | Adjustments                      
Revenue:                      
Total revenue                   7,827 4,891
Cost of revenue:                      
Total cost of revenue                   $ 1,134 $ (170)
[1] See Note 1 for a summary of adjustments.

[2] See Note 1 for a summary of adjustments. The cumulative effect adjustment to Accumulated Deficit and Total Stockholders' Equity related to the adoption of ASU No. 2014-09 (Topic 606) as of June 30, 2016 was $11.8 million.